SCHEMBL926834

SCHEMBL926834

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCc2ccc(F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.50
FKBP1A P62942 1/20 0.44
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
POLB P06746 1/20 0.42
ESRRG P62508 1/20 0.42
TGM2 P21980 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
MMP8 P22894 2/20 0.42
MMP3 P08254 1/20 0.42
NR1I2 O75469 3/20 0.41
NR1H3 Q13133 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927527 0.95 FKBP1A (0.48) RORCFKBP1AALDH1A1MAPK1NPSR1
SCHEMBL926338 0.93 FKBP1A (0.49) FKBP1AALDH1A1MAPK1NPSR1ESRRG
SCHEMBL926686 0.92 ESRRG (0.47) RORCFKBP1AALDH1A1MAPK1NPSR1
SCHEMBL926912 0.92 FKBP1A (0.54) RORCFKBP1AALDH1A1MAPK1NPSR1
SCHEMBL927595 0.92 POLB (0.51) FKBP1AALDH1A1MAPK1NPSR1CA1
SCHEMBL929397 0.91 ESRRG (0.47) RORCFKBP1AALDH1A1MAPK1NPSR1
SCHEMBL926406 0.91 FKBP1A (0.47) FKBP1AALDH1A1MAPK1NPSR1CA1
SCHEMBL928733 0.91 PSEN1 (0.51) FKBP1AALDH1A1MAPK1NPSR1CA1
SCHEMBL927067 0.91 KMT2A (0.47) RORCFKBP1AALDH1A1MAPK1PSEN1
SCHEMBL926157 0.90 RORC (0.51) RORCFKBP1AALDH1A1MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD RORC 42/4885FKBP1A 2748/4885ALDH1A1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.